In the past 20 years, several efforts have been devoted to developing animal models for Alzheimer’s disease (AD), and extensive research has been focused on “curing” animals genetically predisposed to generate amyloid β (Aβ) plaques or neurofibrillary tangles (NFTs) of τ protein. This evidence concerns the gene TBXT and Alzheimer disease.